Lancet Review Confirms mRNA COVID-19 Vaccines Are Safe, Effective, and Paving the Way for Cancer Treatments
By
Anastasia Scott
Summary
A new review published in The Lancet, led by researchers at the University of British Columbia, examines the body of evidence on mRNA COVID-19 vaccines six years after their debut. The review confirms that mRNA vaccines are safe and effective, that serious side effects are rare, and that the same mRNA platform is now being adapted to fight cancer and other diseases beyond COVID-19.
Source
Key quotes
· 3 pulledA new review published in The Lancet has now gone through the body of evidence on what these vaccines did, what they didn't do, and where the technology is going next.
Led by researchers at the University of British Columbia, the review found that mRNA vaccines are safe and effective, that serious side effects are rare, and that the same platform now being used against COVID-19 is already being adapted to fight cancer.
Many people who received an mRNA COVID-19 vaccine had no idea what mRNA was. Some worried it would change their DNA, and others trusted the science without question.
You might also wanna read

A critical review of mRNA vaccine safety and efficacy from mechanistic and public health perspectives
This article provides a critical review of mRNA vaccine safety and efficacy from mechanistic, preclinical, clinical, and public health persp
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti

Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59
This cohort study analyzes data from over 28 million French adults aged 18-59 to examine the association between mRNA COVID-19 vaccination a

HHS Ends mRNA Vaccine Development Under BARDA Following Review
The U.S. Department of Health and Human Services (HHS) has announced the wind-down of its mRNA vaccine development activities under BARDA, i
Long-term HPV vaccine effectiveness study shows stable protection against targeted virus types in Danish women vaccinated as girls
This study examines the long-term effectiveness of HPV vaccination in Danish women who received the 4-valent HPV vaccine as girls in 2008. T

Comments
Sign in to join the conversation.
No comments yet. Be the first.